Please use symbol entry at top right of page to search

Diabetes Drugs Market is expected to generate a revenue of USD 95,157.60 Million by 2030, Globally, at 6% CAGR: Verified Market Research®

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the global Diabetes Drugs Market.

JERSEY CITY, N.J., Feb. 1, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Diabetes Drugs Market" By Drug (Injectable Drugs, Oral Drugs), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Hospital Pharmacies, Rental Pharmacies), and By Geography.


As per the deep research carried out by Verified Market Research®, the global Diabetes Drugs Market size was valued at USD 56,323.63 Million in 2021 and is projected to reach USD 95,157.60 Million by 2030, growing at a CAGR of 6% from 2023 to 2030.

Download PDF Brochure:

Browse in-depth TOC on "Diabetes Drugs Market"

202 - Pages

126 – Tables

37 – Figures

Global Diabetes Drugs Market Overview

Diabetes is a disorder which involves increased levels of blood glucose that can negatively affect various organs such as blood vessels, heart, kidneys, nerves, and eyes. Because of increased levels of blood glucose, it is also termed as hyperglycemia. Body produces insulin, a hormone that regulates the level of glucose in the bloodstream. Diabetes drugs are prescribed to treat type 1 and type 2 diabetes mellitus.

With an increase in the diabetic population, technological improvements and the rising adoption rate in emerging regions are the key factors that might robust the worldwide market. Moreover, a rise in obesity, rising adoption of a sedentary lifestyle, and an upsurge in consumption of unhealthy diet are expected to extend the incidence of diabetes which are expected to fuel the market growth.

Oppositely, the stringent regulatory environment and time-consuming approval process are two main factors that may inhibit the market growth. An increase in the diabetic population, technological advancement, increasing the sales of novel medicines, and growing adoption rate in developing regions are critical factors driving the Diabetes Drugs Market. Additionally, the govt. Taking steps to manage diabetes also increases the expansion of the market. An increasing number of diabetic populations majorly drive the market.

Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The "Global Diabetes Drugs Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Key Players

The "Global Diabetes Drugs Market" study report will provide valuable insight with an emphasis on the global market.  The major players in the market are Novo Nordisk, Biocon, AstraZeneca, Sanofi, BoehringerIngelheim, Eli Lilly, Johnson & Johnson, Pfizer, and Bristol Myers Squibb.

Based on the research, Verified Market Research® has segmented the global Diabetes Drugs Market into Drug, Diabetes Type, Distribution Channel, and Geography.

  • Diabetes Drugs Market, by Drug
    • Injectable Drugs
    • Oral Drugs
    • Insulins
    • Others
  • Diabetes Drugs Market, by Diabetes Type
    • Type 1
    • Type 2
  • Diabetes Drugs Market, by Distribution Channel
    • Hospital Pharmacies
    • Rental Pharmacies
    • Online Pharmacies
    • Others
  • Diabetes Drugs Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Blood Glucose Test Strips Market By Strips Type (Use And Throw, Built-in Indicator), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End-User (Hospitals, Clinics And Diagnostic Centers), By Geography, And Forecast

Human Insulin Market By Application (Type I Diabetes, Type II Diabetes), By Delivery Device (Syringes, Pens, Pen Needles), By Brand (HI Analogs And Biosimilars, HI Biologics), By Type (Insulin Analogs And Biosimilars, HI Biologics), By Product Type (HI Drugs, HI Delivery Devices), By Geography, And Forecast

Diabetes Devices Market By Product (Blood Glucose Monitoring, Insulin Delivery, Pens and Pen Needles), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics and Centers), By End-Use Outlook (Hospitals, Homecare, Diagnostic Centers), By Geography, And Forecast

Diabetes Insulin Pumps Market By Product (Tethered Pumps, Patch Pumps), By Application (Type I Diabetes, Type II Diabetes), By Geography, And Forecast

Top 10 Diabetes Care Devices keeping diabetes at bay internationally

Visualize Diabetes Drugs Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes 
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Follow Us: LinkedIn | Twitter


Cision View original content:

SOURCE Verified Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.